OX40L blockade cellular nanovesicles for autoimmune diseases therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

OX40L blockade cellular nanovesicles for autoimmune diseases therapy

Published:2021-09 Issue: Volume:337 Page:557-570
ISSN:0168-3659
Container-title:Journal of Controlled Release
language:en
Short-container-title:Journal of Controlled Release

Author:

Fu Yu,Wang Leilei,Liu Wei,Yang Lan,Li Lin,Wang Luyao,Sun Xun,Zhang Zhi-rong,Lin Qing,Zhang Ling

Funder

Fundamental Research Funds for the Central Universities

National Natural Science Foundation of China

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference48 articles.

1. Rheumatoid arthritis therapy reappraisal: strategies, opportunities and challenges;Smolen;Nat. Rev. Rheumatol.,2015

2. Evolving concepts of rheumatoid arthritis;Firestein;Nature,2003

3. Neutrophil membrane-coated nanoparticles inhibit synovial inflammation and alleviate joint damage in inflammatory arthritis;Zhang;Nat. Nanotechnol.,2018

4. OX40–OX40 ligand interaction in T-Cell-mediated;Ishii;Immun. Immunopathol.,2010

5. TNF superfamily cytokines in the promotion of Th9 differentiation and immunopathology;Meylan;Semin. Immunopathol.,2017

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Genetically Engineered Cellular Nanovesicles: Theories, Design and Perspective;Advanced Functional Materials;2024-07

2. Sponge-like nano-system suppresses tumor recurrence and metastasis by restraining myeloid-derived suppressor cells-mediated immunosuppression and formation of pre-metastatic niche;Acta Biomaterialia;2023-03

3. Physical- and Chemical-Dually ROS-Responsive Nano-in-Gel Platforms with Sequential Release of OX40 Agonist and PD-1 Inhibitor for Augmented Combination Immunotherapy;Nano Letters;2023-02-13

4. Engineered Cell Membrane Vesicles Expressing CD40 Alleviate System Lupus Nephritis by Intervening B Cell Activation;Small Methods;2023-01-05

5. Cellular nanovesicles for therapeutic immunomodulation: a perspective on engineering strategies and new advances;Acta Pharmaceutica Sinica B;2022-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3